Regulatory Harmonization Institute Company Profile

21:14 EDT 18th June 2018 | BioPortfolio

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development and introduction of meaningful therapies to patients across the globe. RHI will advance global harmonization of regulatory requirements for medicines and devices intended for human use, enabling greater delivery of meaningful new therapies to all patient populations. Visit

News Articles [688 Associated News Articles listed on BioPortfolio]

Regulators In Mexico, Chile And Colombia Take Steps Towards Regulatory Harmonization

Medicines regulators from the Pacific Alliance have taken a step towards greater regional regulatory harmonization in a bid to make...   

China FDA to adopt International Council for Harmonization guidelines

Five safety and regulatory guidelines from the International Council for Harmonization will be implemented by the China FDA,  -More- 

Regulatory roundup: Reviewing global changes in 2017

The pharmaceutical industry made significant advancements towards global regulatory harmonization in 2017 - despite a highly-charged political environment on both sides of the Atlantic. The Trump admi...

US Regulatory Reads, May 2018: Embracing Harmonization, Maturity Models And More

Talk from US FDA officials last month about using the ISO 13485 quality standard to replace all or parts of...   

HIMSS 2006: Harmonization and interoperability getting more than lip service

Walking around the exhibits with my customers and fellow bloggers at HIMSS this year I found that harmonization and iteroperability were two themes that most vendors were touting. Ubiquity of networks...

Harmonized human health risk assessment of plant protection products?

(BfR Federal Institute for Risk Assessment) What strategies exist to ensure independent and transparent risk assessment? How can the scientific dialogue be improved between the various stakeholders? T...

Critical Path Institute receives regulatory support for liver injury biomarker

(Critical Path Institute (C-Path)) The European Medicines Agency (EMA) issued a Letter of Support to C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium for measur...

China moves on to ICH GCP, despite great challenges

China in June 2017 became a member of the e International Council for Harmonization (ICH), showing the…

Drugs and Medications [92 Associated Drugs and Medications listed on BioPortfolio]

Sodium chloride injection usp, 0.9% [Taro Pharmaceuticals U.S.A., Inc.]

Sodium Chloride Injection USP, 0.9%

Sterile water [Hospira, Inc.]

Sterile Water For Injection, USP

Sodium chloride [Hospira, Inc.]


Sodium chloride [General Injectables & Vaccines, Inc]

0.9% Sodium Chloride 0.9% Injection, USP Single Dose vial

Sodium chloride [Hospira, Inc.]

0.9% Sodium Chloride Injection, USP

PubMed Articles [1022 Associated PubMed Articles listed on BioPortfolio]

The roadmap for harmonization: status of the International Consortium for Harmonization of Clinical Laboratory Results.

The International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) was established to fulfill recommendations identified by an international conference convened to review the avail...

Regional Approaches to Expedited Drug Development and Review: Can Regulatory Harmonization Improve Outcomes?

Drug regulatory agencies around the world have implemented programs to expedite drug development and review for promising new products for serious diseases. These programs are all intended to minimize...

A Comparative Study of Medical Device Regulations:: US, Europe, Canada, and Taiwan.

The medical device industry is an industry dealing with multiple types of products covering a wide range of applications. As the safety and effectiveness of medical devices are vital to human health, ...

Harmonization of urine albumin/creatinine ratio (ACR) results: a study based on an external quality assessment program in Polish laboratories.

The ratio of albumin to creatinine (ACR) is an important parameter used for detection of albuminuria in patients with early kidney damage. The aim of the study was to evaluate the harmonization of ACR...

A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays.

Harmonization of units is an important step to improve the comparability of clinical chemistry results, but few examples exist of successful harmonization efforts. We present the results of a pragmati...

Clinical Trials [1031 Associated Clinical Trials listed on BioPortfolio]

The Differential Effects of 3 Different Immunosuppressive

The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive the...

T-Regulatory Cells in Amyotrophic Lateral Sclerosis

This is an open-label pilot study to determine the safety and tolerability of infusions of autologous CD4+ CD25+ regulatory T cells with concomitant subcutaneous IL-2 injections in 4 subje...

Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group

Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17

Messages for Increasing Dairy Consumption

Over 35,000 Canadians, 65% of men and 72% of women aged 31-50 years fail to consume the recommended number of milk and milk product servings (≤2 servings per day). Given the wide range o...

Eylea Regulatory Post Marketing Surveillance(rPMS)

The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by KFDA.

Companies [1967 Associated Companies listed on BioPortfolio]

Regulatory Harmonization Institute, Inc.

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development...

Regulatory Harmonization Institute

Regulatory Harmonization Institute, Inc. (RHI) is a non-profit association dedicated to global harmonization of regulatory requirements with a mission to influence the development...

Phase Forward

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in o...

Phase Forward Incorporated

Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward's products and services have been utilized in over 1...

Critical Path Institute (C-Path)

The Critical Path Institute (C-Path) is an independent, non-profit organization established in 2005 with public and private philanthropic support from the Arizona community, Scien...

More Information about "Regulatory Harmonization Institute" on BioPortfolio

We have published hundreds of Regulatory Harmonization Institute news stories on BioPortfolio along with dozens of Regulatory Harmonization Institute Clinical Trials and PubMed Articles about Regulatory Harmonization Institute for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Regulatory Harmonization Institute Companies in our database. You can also find out about relevant Regulatory Harmonization Institute Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record